Diabetes and kidney disease: emphasis on treatment with SGLT-2 inhibitors and GLP-1 receptor agonists
Monitor liver enzymes (ALT, AST), metabolic parameters (HbA1c, lipids), and fibrosis scores (FIB-4) every 36 months
Depending on what you need, you can: Use the dashboard to track progress, habits, and patterns in one place Follow a clear, structured Guided Plan tailored to how you eat Or access the full system for flexibility, support, and long-term consistency This is not just another plan its a way to stay consistent without overthinking every decision
Insurance plans may still use prior authorizations, formulary restrictions, or step therapy requirements even after lower-cost versions become available